Berwyn, Pa.-based Fresenius Vascular Care, one of its executives and several affiliates were named in the New Jersey lawsuit, and they are accused of violating the New Jersey False Claims Act as well as New York and Georgia laws.
The suit alleges that the centers scheduled end-stage renal disease patients for invasive procedures every three to four months, purportedly to preserve their dialysis access sites. Investigators said most patients had no problems receiving dialysis and the surgeries were unnecessary. The center is also accused of falsifying patient referrals, ignoring relevant medical records and falsifying diagnostic reports to justify billing for repeat procedures.
The suit also alleges that the centers pressured its providers to adopt the scheme and created incentives to maximize the number of procedures performed on dialysis patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
